Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. (ADVM) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
ADVM · net income · updated Jun 9, 2026
Core profitability metrics
ADVM · net income · margin · TTM · CAGRNet income was −$130.9M for FY2024 (fiscal year ending 2024-12-31), down 7.2% year-over-year. Net profit margin was -13092.7%.
Annual net income history
▸ FMP /income-statement · Annual · ADVM net income history · ADVM profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Adverum Biotechnologies, Inc. (ADVM) reported net income of −$130.9M for FY2024 (fiscal year ending 2024-12-31), down 7.2% year-over-year. The net profit margin was -13092.7% — meaning the company kept $-130.93 of every dollar of revenue as profit.
Adverum Biotechnologies, Inc. has not yet achieved annual profitability based on available data (13 fiscal years). The company has reported net losses across all available periods.
Adverum Biotechnologies, Inc.'s net profit margin was -13092.7% for FY2024, based on the latest annual results.
Investors sometimes search for "Adverum Biotechnologies, Inc. net worth" — the company's market capitalization is a separate figure from ADVM net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
ADVM net income · 4 questionsAdverum Biotechnologies, Inc. is not currently profitable on an annual basis. The company reported a net loss of $130.9M for FY2024.
▸ Source: FMP /income-statement · GAAP · Adverum Biotechnologies, Inc. · Adverum Biotechnologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026